ANGELA SOYOMBO: Open Payments
NPI 1326584665 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 23 payments from 10 companies in 2025. Trend: 2023 $343 · 2024 $196 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $84 |
| Madrigal Pharmaceuticals | 5 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Baxter Healthcare | 1 | $43 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Caris MPI, Inc. | 1 | $19 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
Products named: XIFAXAN, REZDIFFRA, LIVTENCITY, PERCLOT, TEFLARO, ZERBAXA, Exparel, TERLIVAZ.
Industry payments across TX — which companies pay providers there.
